Literature DB >> 3971203

Thrombocytopenia accompanying a reaction to protamine sulfate.

J C Horrow.   

Abstract

Catastrophic pulmonary vasoconstriction, an idiosyncratic reaction to protamine, occurred following cardiopulmonary bypass in a patient with mitral regurgitation. One minute following intravenous injection of 10 mg of protamine, systemic blood pressure decreased precipitously, accompanied by elevated pulmonary arterial pressure, decreased left atrial pressure, and a dilated and poorly contracting right ventricle. These changes spontaneously reversed over five minutes. Rechallenge with protamine was uneventful. Platelet count decreased from 76,000/mm3 to 12,000/mm3. Transient thrombocytopenia occurs predictably in dogs given protamine rapidly. Suggested mechanisms of idiosyncratic pulmonary vasoconstriction in patients should consider the role of the associated thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971203     DOI: 10.1007/bf03008537

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  12 in total

1.  A study of the toxicity of the protamine, salmine.

Authors:  L B JAQUES
Journal:  Br J Pharmacol Chemother       Date:  1949-06

2.  Pulmonary venoconstriction by induced platelet aggregation.

Authors:  K Rådegran; U Drugge; P Olsson
Journal:  Acta Anaesthesiol Scand       Date:  1974       Impact factor: 2.105

3.  Circulatory and ventilatory effects of induced platelet aggregation and their inhibition by acetylsalicylic acid.

Authors:  K Rådegran; C McAslan
Journal:  Acta Anaesthesiol Scand       Date:  1972       Impact factor: 2.105

4.  Mode of action of protamine in regard to its circulatory and respiratory side effects.

Authors:  K Rådegran; G A Taylor; P Olsson
Journal:  Eur Surg Res       Date:  1971       Impact factor: 1.745

5.  Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.

Authors:  H J Stefaniszyn; R J Novick; T A Salerno
Journal:  J Thorac Cardiovasc Surg       Date:  1984-05       Impact factor: 5.209

6.  Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.

Authors:  E Lowenstein; W E Johnston; D G Lappas; M N D'Ambra; R C Schneider; W M Daggett; C W Akins; D M Philbin
Journal:  Anesthesiology       Date:  1983-11       Impact factor: 7.892

7.  Classical pathway activation during an adverse response to protamine sulphate.

Authors:  N Best; B Teisner; J G Grudzinskas; M M Fisher
Journal:  Br J Anaesth       Date:  1983-11       Impact factor: 9.166

8.  On the mechanism of platelet aggregation induced by heparin, protamine and polybrene.

Authors:  C Eika
Journal:  Scand J Haematol       Date:  1972

9.  The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.

Authors:  B Milne; K Rogers; F Cervenko; T Salerno
Journal:  Can Anaesth Soc J       Date:  1983-07

10.  Platelet aggregation following heparin and protamine administration.

Authors:  N Ellison; L H Edmunds; R W Colman
Journal:  Anesthesiology       Date:  1978-01       Impact factor: 7.892

View more
  1 in total

1.  Ketanserin in the treatment of protamine-induced pulmonary hypertension.

Authors:  P J van der Starre; C Solinas
Journal:  Tex Heart Inst J       Date:  1996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.